Skip to main content

Identification of higenamine in Radix Aconiti Lateralis Preparata as a beta2-adrenergic receptor agonist

Buy Article:

$51.00 plus tax (Refund Policy)

Abstract:

Abstract

Aim: To screen beta2-adrenergic receptor (2-AR) agonists from Radix Aconiti Lateralis Preparata (RALP) as potential drug leads for asthma using a sensitive cell-based agonist assay. Methods: The 2-AR gene was stably expressed by Chinese hamster ovary (CHO) cells also stably expressing a cyclic adenosine monophosphate (AMP) response element-linked enhanced green fluorescent protein reporter gene. The cells were used to screen agonists from high-performance liquid chromatographic fractions of an extract of RALP. The fraction with the highest activity was selected for further compound isolation and the study of the structure-activity relationship. Its active compound was further identified by chromatography and mass spectrometry. Results: Bioactivity-directed fraction-ation of the crude extract of RALP led to the isolation and characterization of the effective compound, namely hignamine. It could dose-dependently relax the isolated guinea pig trachea strip precontraction with acetylcholine with EC50 value of (2.60±0.36) × 10−5 mol/L. Further in vivo studies also displayed that hignamine could protect experimental asthma model induced by histamine in guinea pigs to prolong the latent periods of asthma. Conclusion: Hignamine, as a 2-AR agonist existing in the extract of RALP, is the key compound contributing to the successful relief of the bronchoconstriction.

Keywords: Radix Aconiti Lateralis Preparata (RALP); asthma; beta2-adrenergic receptor (2-AR) agonists; herbal medicines; higenamine

Document Type: Research Article

DOI: https://doi.org/10.1111/j.1745-7254.2008.00859.x

Affiliations: 1: College of Life Sciences, Nankai University, Tianjin 300071, China 2: College of Pharmaceutical Sciences, Nankai University, Tianjin 300071, China

Publication date: 2008-10-01

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more